tbuckley/cabot-search huggingface dataset:
FOREIGN CORRESPONDENCE.
Authors: None G. O. M.
Journal: JAMA (1884)

London, Feb.7, 1884. The Anthropological Society, at their annual meeting, had an entertaining paper read by Professor Flower, F.R.S., in which he dealt with the subject of ethnography, or the discrimination of race characteristics. Its importance to those who had to rule, he said, could hardly be overestimated in an empire like this, the population of which was composed of almost every diversity under which the human body and mind could manifest itself. The physical characteristics of race, so strongly marked in many cases, were probably always associated with equally or more diverse characteristics of temper and intellect. It was absolutely necessary, therefore, for the statesman who would govern successfully not to look upon human nature in the abstract, and endeavor to apply universal rules, but to consider the special moral, intellectual and social capabilities, wants and aspirations of each particular race with which he had to deal. A
Topical anesthesia during circumcision in newborn infants
Authors: F. Benini
Journal: JAMA (1993)

<h3>Objective.</h3> —To determine the efficacy of topical anesthetic cream, eutectic mixture of local anesthetics (EMLA), in alleviating pain from neonatal circumcision. <h3>Design.</h3> —Randomized, controlled trial. <h3>Setting.</h3> —Normal newborn nursery in a university teaching hospital. <h3>Patients.</h3> —Twenty-seven newborn, full-term male neonates, aged 1 to 3 days. <h3>Outcome Measures.</h3> —Heart rate, transcutaneous oxygen saturation, facial activity, and crying. <h3>Results.</h3> —Compared with baseline, all newborns experienced pain as evidenced by increased heart rate of an average of 40 beats per minute (F [8, 25]=14.12;<i>P</i>&lt;.0001), decreased oxygen saturation of 3% (F [8, 25]=15.02;<i>P</i>&lt;.0001), and more facial actions indicative of pain (F [8, 25]=5.25;<i>P</i>&lt;.002) during all phases of the procedure. Compared with placebo, EMLA significantly attenuated the pain response as shown by lower heart rate of an average of 25 beats per minute (F [1, 25]=14.92;<i>P</i>&lt;.001), higher oxygen saturation of 5%, particularly during the clamping and lysis phases (F [1, 25]=19.83;<i>P</i>&lt;.0001), 20% less facial activity (F [1, 25]=12.01;<i>P</i>&lt;.002), and 15% less crying during the clamping, Gomco clamp application, and incision of the foreskin. There were no differences between groups in the spectral crying parameters. <h3>Conclusions.</h3> —Circumcision procedure produces pain responses that EMLA diminishes. Thus, EMLA may be a useful agent for pain management in neonatal circumcision. (<i>JAMA</i>. 1993;270:850-853)
Reports of Standing Committees of the House of Delegates
Journal: JAMA (1960)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Die Haut- und Geschlechtskrankheiten: Eine zusammenfassende Darstellung für die Praxis
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Extracellular vesicles derived from human umbilical cord mesenchymal stem cell protect liver ischemia/reperfusion injury by reducing CD154 expression on CD4+ T cells via CCT2.
Authors: Xiaomei Zhang, Yingcai Zhang, Jia Yao, Jianye Cai, Tongyu Lu, Jun Zheng, Jiebin Zhang, Wei Liu, Liang Chen
Journal: Journal of Hepatology (2020)
Erroneous Geographical Label.
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ANESTHETIC FATALITIES
Authors: James T. Gwathmey
Journal: JAMA (1923)

<h3>To the Editor:</h3> —In Queries and Minor Notes (The Journal, July 28, p. 320), under the caption, "Ethyl Chlorid as a General Anesthetic," there is misinformation concerning the comparative dangers of ethyl chlorid with other anesthetics. If the inquirer does only what he says—uses ethyl chlorid to "produce unconsciousness and then switch to ether"—his present technic as regards<i>safety</i>cannot be improved on, as the only deaths recorded under ethyl chlorid have been with the patient in full surgical anesthesia. The inquirer's technic is considered especially safe for children. With adults, the "margin of safety" is increased by preliminary medication (<i>New York M. J.</i>, Oct. 28 and Nov. 4, 1916). The answer further states that "the fair comparison for ethyl chlorid is with nitrous oxid. Ethyl chlorid is somewhere between 200 and 66 times more dangerous than nitrous oxid." In 1911, circulars were sent to ninety-nine hospitals widely separated in
Preadmission screening of Medicare patients
Authors: James E. Barone
Journal: JAMA (1988)

<h3>To the Editor.—</h3> The article entitled "Preadmission Screening of Medicare Patients"<sup>1</sup>did not address an important issue that I feel must be considered when discussing the effectiveness of such a program. What is the cost of preadmission screening? Using data from the article, one could surmise that at least 115 000 telephone calls are received per year. I would like to know how many nurse reviewers, physician reviewers, and secretaries are needed to staff the program. What is the cost of the office rental and supplies? On a yearly basis, one could expect about 400 admission denials, with about half of these patients eventually being admitted anyway. If the program costs $1 million per year to run, each true denial will result in a $5000 expenditure. Of course, I ignore the cost of wasted man-hours on the part of practicing physicians and their personnel while repeatedly dialing the telephone
Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.
Authors: Isabel Smith
Journal: BMJ (1993)

Efficient neonatal screening for phenylketonuria and the availability of complex diets for lifelong use have virtually eliminated severe mental handicap from the disease. Nevertheless, there remains a high risk of fetal damage in offspring of women with the disease, and the possibility that the diets themselves may be harmful cannot be excluded. Search for a preventive treatment for the disease has been greatly aided by advances in molecular genetics. For example, in mice modified liver cells have been implanted, which have not only corrected the phenylalanine defect but have remained healthy for the normal life span of the animal. Overall, however, prevention and treatment have not progressed as quickly as was hoped, and research and development must be pursued vigorously to take account of contemporary perceptions of the disorder.
Acute leukemia in pregnancy. Successful delivery after cytarabine and doxorubicin
Authors: M. Newcomb
Journal: JAMA (1978)

ACUTE leukemia is not rare in adults of reproductive age. With the advent of increasingly effective chemotherapeutic regimens, 62% of patients with leukemia from 20 to 34 years of age can be expected to obtain complete remission. The median anticipated length of survival presently exceeds 60 weeks, and we hope this will improve rapidly.<sup>1</sup>Therefore, the management of leukemia during pregnancy will require increasing attention. Management decisions are difficult, and data are sparse. One important consideration is the potential effect of chemotherapy on the fetus. Two women received intensive chemotherapy and achieved remission while carrying pregnancies to term. <h3>Report of Cases</h3><h3>Case 1.—</h3> A 22-year-old woman, gravida 2 and para 1, was admitted to the University Hospital on Sept 14, 1973, with a three-week history of increasing weakness and melena. She was approximately four months pregnant according to history. At the time of admission, she had a temperature of 38.7
CONTRACEPTION AND BIRTH CONTROL
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstracts of Articles Published by Members of the Staff of the National Cancer Institute
Journal: JNCI Journal of the National Cancer Institute (1949)

Abstracts of Articles Published by Members of the Staff of the National Cancer Institute JNCI: Journal of the National Cancer Institute, Volume 10, Issue 1, August 1949, Pages 215–220, https://doi.org/10.1093/jnci/10.1.215 Published: 01 August 1949
The Sex Difference in Tumor Incidence Is Related to the Female Condition: Models for Europe and Italy
Authors: Romualdo Benigni, Rosa Giaimo, Domenica Matranga, Alessandro Giuliani
Journal: Environmental Health Perspectives (2001)

A remarkable aspect of cancer distribution in Europe is the large spatial variability of the male-female incidence ratio, from no difference up to 50%. Given the evidence of the predominantly environmental origin of cancer, we studied the ability of a set of socioeconomic indicators of the female condition to model the spatial variability of the sex difference in tumor incidence at two different scales: between countries (Europe) and between provinces (Italy). The sex difference in tumor incidence correlated with female socioeconomic condition indicators at the same extent (r = 0.73) in both situations, but in opposite directions. In the European study the higher the sexual social equality the lower the differential tumor incidence, whereas the opposite result was shown by the between-provinces Italian study. We also investigated the relation of the female condition indicator with other social and cultural descriptors of the same populations, and we suggest explanatory models linking female condition and pathology at the continental and local scales. Overall, our analysis supports the predominantly environmental origin of cancer and stresses the importance of relating cancer patterns to societal determinants. Our analysis also suggests that the sex difference in tumor incidence is a very useful probe for exploring the social-economic cultural correlates of cancer in human populations. We emphasize the need for a thorough analysis of the empirical correlations highlighted in ecologic studies.
CANCER RESEARCH AT THE MIDDLESEX HOSPITAL IN LONDON.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
GETTING RICH "BY DEGREES" IN ITALY.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Part 6: Advanced Cardiovascular Life Support
Authors: IAC-CPR includes manual compression of the abdomen by an extra rescuer during the relaxation phase of chest compression., The abdominal compression point is located in the midline, halfway between the xiphoid process and the umbilicus (Figure, ). The recommended force of abdominal compression should be sufficient to generate approximately 100 mm Hg external pressure on the abdominal aorta and vena cava and is equivalent to that required to optimally palpate the aortic pulse when the heart is beating normally.
Journal: Circulation (2000)
Acute leukemia following cytotoxic chemotherapy
Authors: R. A. Kaslow
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Jay McLean (1890-1957), discoverer of heparin
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Azacitidine in the Treatment of Elderly Patients with Acute Myelogenous Leukemia.
Authors: Heather L. Benjamin, James M. Rossetti, Aaron J. Lampkin, Christie Hilton, Entezam Sahovic, Haifaa Abdulhaq, Richard K. Shadduck, Namratha Vemulapalli, Amanda Hercules, John Lister
Journal: Blood (2009)
Standards and Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care (ECC)
Journal: JAMA (1980)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tumor necrosis factor–alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis
Authors: James F. Whiting, Richard M. Green, Adam B. Rosenbluth, John L. Gollan
Journal: Hepatology (1995)

Tumor necrosis factor–alpha (TNF,α), a cytokine that is produced in a variety of inflammatory diseases associated with cholestasis, is believed to be the primary mediator of the systemic effects of endotoxin. Thus, we have investigated the role of TNFα in the pathogenesis of endotoxin-induced cholestasis in intact animals, and in the uptake of taurocholate by cultured hepatocytes. Male Sprague-Dawley rats received either intravenous (IV) endotoxin (7.5 mg/kg) or monoclonal anti-TNFα antibody followed by endotoxin. Basal bile flow and bile salt excretion were measured for a 2-hour period, after which all animals received an IV bolus of taurocholate (10 μmol/100 g body weight). Endotoxin decreased basal bile flow by 41% and bile salt stimulated bile flow by 38% (n = 12; P < .01). Basal bile salt excretion was decreased 86% after endotoxin administration. Passive immunization with anti-TNFα antibody blocked this endotoxin-associated cholestasis. In addition, rat hepatocytes were isolated and cultured in the presence of either endotoxin (10 μg/mL) or TNFα (100 ng/mL) for 24 hours. These primary hepatocyte cultures exhibited a dose- and timedependent, noncompetitive, inhibition of taurocholate uptake. We postulate that TNFα is an important mediator of the cholestasis of sepsis. (HEPATOLOGY 1995; 22:1273–1278.).